The US Food and Drug Administration (FDA) on Wednesday released final guidance for sponsors on when a standard release test and criteria may be used in lieu of extensive method development and ...
The FDA issued a voluntary recall of Xanax XR manufactured by Viatris due to failure to meet dissolution specifications, which could make the drug less effective. Experts advise continuing your ...
Pharmaceutical company Viatris Specialty LLC voluntarily recalled one lot of Xanax XR (alprazolam extended-release 3 mg) tablets on March 17, 2025, after routine quality testing revealed the pills ...
The US Food and Drug Administration (FDA) on Thursday issued new draft guidance covering the quality attributes drugmakers should consider when developing chewable tablets. The guidance also includes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results